Tarsons Products

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE144Z01023
  • NSEID: TARSONS
  • BSEID: 543399
INR
223.20
-5.4 (-2.36%)
BSENSE

Dec 05

BSE+NSE Vol: 58.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Tarsons Products Ltd stock-summary
stock-summary
Tarsons Products Ltd
Small Cap
Healthcare Services
Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983. The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.64 Cr
Number of Shares
5.32 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Nov-2021
5.32
10.64
2265861
2
Public Issue
26-Jun-2021
5.09
10.19
49979280
2
Bonus Issue
14-Jun-2021
9.61
0.19
768912
2
Stock Split
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 13 FIIs (5.82%)

Promoter with highest holding

Sanjive Sehgal (26.98%)

Highest Public shareholder

Clear Vision Investment Holdings Pte Limited (23.42%)

Individual Investors Holdings

17.14%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Sanjive Sehgal
Chairman & Managing Director
4.25 cr
Rohan Sehgal
Whole-time Director
3.75 cr
Gaurav Podar
Nominee
0
Viresh Oberai
Independent Director
12.0 lacs
Sucharita Basu
Independent Director
12.0 lacs
Girish Paman Vanvari
Independent Director
12.0 lacs
SANTOSH KUMAR AGRAWAL
Chief Finance Officer & CS
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Plastic products instruments
11.491
0%
 
100
Plastic products instruments
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
102 Cr
(Quarterly Results - Sep 2025)
Net Profit:
3 Cr
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 1,199 Cr (Small Cap)

stock-summary
P/E

59.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.58

stock-summary
Return on Equity

3.28%

stock-summary
Price to Book

1.94